Arkolith/Insider Trading/XFOR/Form 4

Craig Adam R

Executive Chairman, DirectorX4 Pharmaceuticals, Inc (XFOR) · full profile →Form 4 · filed Oct 27, 2025
Net Buying
Open-Market Buys
$250K
Open-Market Sells
$0
Net Open-Market Flow
$250K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Oct 23, 2025Buy(P)86K$2.90$250K376K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001501697-25-000035) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML